UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis

Drugs & aging, 2020-11, Vol.37 (11), p.801-816

2020

Volltextzugriff (PDF)

Penile Weight and Cell Subtype Specific Changes in a Post-Radical Prostatectomy Model of Erectile Dysfunction

The Journal of urology, 2003-03, Vol.169 (3), p.1175-1179

2003

Volltextzugriff (PDF)

Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study

Neurourology and urodynamics, 2020-06, Vol.39 (5), p.1378-1386

2020

Volltextzugriff (PDF)

Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study

Lower urinary tract symptoms, 2021-10, Vol.13 (4), p.425-434

2021

Volltextzugriff (PDF)

Acute Right Varicocele: A Clue to Congenital Vascular Anomaly

Urology (Ridgewood, N.J.), 2015-05, Vol.85 (5), p.e39-e40

2015

Volltextzugriff (PDF)

Management of Recurrent Pelvic Fluid Collections in Adult Male Bladder Exstrophy Patients With Maintenance of Erectile Function

Urology (Ridgewood, N.J.), 2019-03, Vol.125, p.256-259

2019

Volltextzugriff (PDF)

Completely Intracorporeal Robotic-assisted Laparoscopic Augmentation Enterocystoplasty With Continent Catheterizable Channel

Urology (Ridgewood, N.J.), 2014-12, Vol.84 (6), p.1314-1318

2014

Volltextzugriff (PDF)

The UroCuff test: a non-invasive alternative to pressure flow studies in adult males with lower urinary tract symptoms secondary to bladder outlet obstruction

Canadian journal of urology, 2015-08, Vol.22 (4), p.7896

2015

Volltextzugriff (PDF)

1517 EFFICACY OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC BLADDER AND DECREASED BLADDER COMPLIANCE

The Journal of urology, 2011, Vol.185 (4), p.e608-e608

2011

Volltextzugriff (PDF)

Longitudinal transcriptome profiling of localized hormone-sensitive tumors in treatment-naïve ENACT patients with prostate cancer with and without enzalutamide (ENZA)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5026-5026

2023

Volltextzugriff (PDF)

Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study

Urology (Ridgewood, N.J.), 2018-10, Vol.120, p.205-210

2018

Volltextzugriff (PDF)

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

The Journal of urology, 2020-06, Vol.203 (6), p.1163-1171

2020

Volltextzugriff (PDF)

Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States

Neurourology and urodynamics, 2020-11, Vol.39 (8), p.2206-2222

2020

Volltextzugriff (PDF)

Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case–Control Cohort Analysis

Advances in therapy, 2020-11, Vol.37 (11), p.4599-4613

2020

Volltextzugriff (PDF)

Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study

Urology (Ridgewood, N.J.), 2021-01, Vol.147, p.235-242

2021

Volltextzugriff (PDF)

Diagnostic discordance of electromyography (EMG) versus voiding cystourethrogram (VCUG) for detrusor-external sphincter dyssynergy (DESD)

Neurourology and urodynamics, 2005, Vol.24 (7), p.616-621

2005

Volltextzugriff (PDF)

Reply by Authors

The Journal of urology, 2020-06, Vol.203 (6), p.1171-1171

2020

Volltextzugriff (PDF)

MP62-17 ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACT

The Journal of urology, 2021-09, Vol.206 (Supplement 3)

2021

Volltextzugriff (PDF)

A NOVEL ENDOSCOPIC APPROACH TOWARDS RESECTION OF THE DISTAL URETER WITH SURROUNDING BLADDER CUFF DURING HAND ASSISTED LAPAROSCOPIC NEPHROURETERECTOMY

The Journal of urology, 2001-02, Vol.165 (2), p.483-485

2001

Volltextzugriff (PDF)

LBA-03 EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial

JAMA oncology, 2022-08, Vol.8 (8), p.1128

2022

Volltextzugriff (PDF)

The Symptoms of Lower Urinary Tract Dysfunction Research Network

The Journal of urology, 2016-07, Vol.196 (1), p.146-152

2016

Volltextzugriff (PDF)

Symptom scores: mumbo jumbo or meaningful measures?

Current urology reports, 2005-08, Vol.6 (4), p.251-256

2005

Volltextzugriff (PDF)

1517 EFFICACY OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC BLADDER AND DECREASED BLADDER COMPLIANCE

The Journal of urology, 2011-04, Vol.185 (4), p.e608-e608

2011

Volltextzugriff (PDF)

Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance

JCO precision oncology, 2024-04, Vol.8, p.e2300603

2024

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(75)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis

Penile Weight and Cell Subtype Specific Changes in a Post-Radical Prostatectomy Model of Erectile Dysfunction

Undertreatment of overactive bladder among men with lower urinary tract symptoms in the United States: A retrospective observational study

Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study

Acute Right Varicocele: A Clue to Congenital Vascular Anomaly

Management of Recurrent Pelvic Fluid Collections in Adult Male Bladder Exstrophy Patients With Maintenance of Erectile Function

Completely Intracorporeal Robotic-assisted Laparoscopic Augmentation Enterocystoplasty With Continent Catheterizable Channel

The UroCuff test: a non-invasive alternative to pressure flow studies in adult males with lower urinary tract symptoms secondary to bladder outlet obstruction

1517 EFFICACY OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC BLADDER AND DECREASED BLADDER COMPLIANCE

Longitudinal transcriptome profiling of localized hormone-sensitive tumors in treatment-naïve ENACT patients with prostate cancer with and without enzalutamide (ENZA)

Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study

Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States

Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case–Control Cohort Analysis

Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study

Diagnostic discordance of electromyography (EMG) versus voiding cystourethrogram (VCUG) for detrusor-external sphincter dyssynergy (DESD)

Reply by Authors

MP62-17 ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACT

A NOVEL ENDOSCOPIC APPROACH TOWARDS RESECTION OF THE DISTAL URETER WITH SURROUNDING BLADDER CUFF DURING HAND ASSISTED LAPAROSCOPIC NEPHROURETERECTOMY

LBA-03 EFFICACY AND SAFETY OF MIRABEGRON VS. PLACEBO ADD-ON THERAPY IN MEN WITH OVERACTIVE BLADDER SYMPTOMS RECEIVING TAMSULOSIN FOR UNDERLYING BENIGN PROSTATIC HYPERPLASIA (PLUS)

Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial

The Symptoms of Lower Urinary Tract Dysfunction Research Network

Symptom scores: mumbo jumbo or meaningful measures?

1517 EFFICACY OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC BLADDER AND DECREASED BLADDER COMPLIANCE

Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance

Suchergebnisse filtern